PGR and breast neoplasm: Increased high-grade tumors were found in the HBOC-risk group (45%), representing an important factor of worse prognosis and lower survival.16A similar result was found by Amendola & Vieira, according to whom patients with hereditary breast neoplasms had increased prevalence of high-grade disease, frequently related to negative estrogen and progesterone receptors.17